Rchr

J-GLOBAL ID：200901078532512678 Update date: Aug. 27, 2020

Kuriyama Masaru

クリヤママサル | Kuriyama Masaru

Research field (3)： Neurology , Internal medicine - General , Neuroscience - general

Research theme for competitive and other funds (4)：

神経化学
臨床神経学
Neuro chemistry
Clinical Neurology

MISC (49)：

M Hirayama, M Kuriyama. MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine - Possible presence of glutamate receptor and muscarinic receptor on microglia. BRAIN RESEARCH. 2001. 897. 1-2. 204-206
Y Kitagawa, K Hashimoto, M Kuriyama. Hypertrophic branchial myopathy with uniform predominance of type 1 fibres. SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY. 2000. 34. 4. 391-396
T Mutoh, T Hamano, A Tokuda, M Kuriyama. Unglycosylated Trk protein does not co-localize nor associate with ganglioside GM1 in stable clone of PC12 cells overexpressing Trk (PCtrk cells). GLYCOCONJUGATE JOURNAL. 2000. 17. 3-4. 233-237
T Kumano, T Mutoh, H Nakagawa, M Kuriyama. HMG-CoA reductase inhibitor induces a transient activation of high affinity nerve growth factor receptor, Trk, and morphological differentiation with fatal outcome in PC12 cells. BRAIN RESEARCH. 2000. 859. 1. 169-172
T Hamano, T Mutoh, H Sugie, H Koga, M Kuriyama. Phosphoglycerate kinase deficiency: An adult myopathic form with a novel mutation. NEUROLOGY. 2000. 54. 5. 1188-1190

ｍore...

Education (2)：

- 1972 Kagoshima University Faculty of Medicine
- 1972 Kagoshima University Faculty of Medicine

Professional career (1)：

(BLANK) (Kagoshima University)

Work history (1)：

University of Fukui Faculty of Medical Sciences, School of Medicine

Committee career (8)：

日本神経感染症学会評議員
日本神経免疫学会評議員
日本老年病学会評議員
日本臨床代謝学会評議員
日本神経治療学会理事

Show all

Association Membership(s) (8)：

日本神経感染症学会 , 日本神経免疫学会 , 日本老年病学会 , 日本臨床代謝学会 , 日本神経治療学会 , 日本動脈硬化学会 , 日本内科学会 , 日本神経学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM